ArticleQuantitative biology (Beijing, China)2026
The evaluation crisis in artificial intelligence-driven computational biology: Pitfalls and solutions.
Article in Quantitative biology (Beijing, China), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial intelligence (AI) is rapidly transforming computational biology. However, closer scrutiny reveals that many reported results do not hold under rigorous evaluation. This paper identifies prevalent, recurring issues in the field, including narrow datasets, hidden confounders that make supposedly independent test data effectively indistinguishable from the training data (the doppelgänger effect), misleading performance metrics, and over-reliance on overly easy test cases. We argue that meaningful assessment must go beyond metric-centric model evaluation to encompass biological realism, data diversity, confounding control, and interpretability. Crucially, AI studies in computational biology should deliver not only predictive performance but also genuine biological insight and transferable methodological understanding. To address these systemic limitations, we propose a unifying framework, VALID, comprising the following five guiding principles for rigorous AI in biology: Veracious biological grounding and novelty, artifact control and methodological rigor, legitimate generalization, inspectable preprocessing, and deployment-aware performance. Together, these principles serve as a diagnostic lens for structuring our discussion throughout this paper. We further illustrate common pitfalls through representative examples and provide actionable guidance for authors, reviewers, and editors aimed at improving the rigor and scientific value of AI-driven computational biology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.